by EmpathiCSubstanceS | Aug 17, 2022 | Psilocybin Magic Mushroom
The present pilot study demonstrated that up to 2 mg of psilocybin delivered as a slow intravenous injection produces short-lived but typical drug effects that are psychologically and physiologically well tolerated. With appropriate care, this study supports the...
by EmpathiCSubstanceS | Aug 17, 2022 | Psychedelic Research
Participants’ responses to psilocybin were qualitatively similar to those described in other populations. Abstinence did not increase significantly in the first 4 weeks of treatment (when participants had not yet received psilocybin), but increased significantly...
by EmpathiCSubstanceS | Aug 17, 2022 | Psilocybin Magic Mushroom, Psychedelic Research
Robust activations to the memories were seen in limbic and striatal regions in the early phase and the medial prefrontal cortex in the late phase in both conditions (P<0.001, whole brain cluster correction), but there were additional visual and other sensory...
by EmpathiCSubstanceS | Aug 17, 2022 | Microdosing
We found that both convergent and divergent thinking performance was improved after a non-blinded microdose, whereas fluid intelligence was unaffected. While this study provides quantitative support for the cognitive-enhancing properties of microdosing psychedelics,...
by EmpathiCSubstanceS | Aug 17, 2022 | Psychedelic Research, San Pedro Mescaline
Acute administration of 2C-B increased blood pressure and heart rate. Scores of scales related to euphoria increased (high, liking, and stimulated), and changes in perceptions (distances, colors, shapes, and lights) and different body feelings/surrounding were...
